Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.81 | ||
| Change(%) | ![]() | 0.00 | |
| Volume | 268786 | ||
| 1:28 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon Concludes Tender Offer for a Portion of Its Debt
Enzon Reports Solid Second Quarter 2008 Results
-- Product revenues increase 17% --
Enzon Pharmaceuticals to Add New Independent Director to Board
Enzon's PEG-SN38 Featured in Clinical Cancer Research

Enzon's Board of Directors Reaffirms Support of its Chairman and CEO
Enzon Discontinues Further Development of rhMBL
Enzon Reports Third Quarter 2007 Results
Enzon Pharmaceuticals Commences Tender Offer For a Portion of its Debt
